Neuron-Specific Enolase (NSE) Test: Uses, Levels & Results

What Is Neuron-Specific Enolase (NSE)?

Neuron-specific enolase (NSE) is an enzyme found mainly in neurons and neuroendocrine cells. When these cells are damaged or grow rapidly, NSE leaks into the bloodstream, making it a valuable biomarker for certain cancers, particularly small cell lung cancer (SCLC), and for assessing brain injury severity.

In my clinical practice, I often see NSE ordered as part of a tumour marker panel when a lung nodule raises suspicion for SCLC, or to monitor treatment response in patients already diagnosed with neuroendocrine tumours.

Why Is the NSE Test Ordered?

Doctors typically request this test for:

• Diagnosis and monitoring of small cell lung cancer – NSE levels correlate with tumour burden and can help distinguish SCLC from other lung cancers.
• Neuroblastoma evaluation in children – Elevated NSE often indicates disease activity.
• Assessment of traumatic brain injury (TBI) – Higher NSE levels are associated with more severe injury and poorer outcomes.
• Follow-up after treatment – Falling NSE suggests a good response; rising NSE may signal recurrence.

NSE Reference Ranges by Age and Gender

Normal values vary slightly between laboratories, but the typical adult range is <12.5 µg/L. Children often have slightly higher levels due to ongoing neurodevelopment. The table below shows common reference intervals used in clinical settings.

What Does a High NSE Level Mean?

A significantly elevated NSE is not diagnostic on its own, but it raises suspicion for:

• Small cell lung cancer – Levels above 25 µg/L are common in active SCLC.
• Neuroblastoma – Particularly in young children.
• Medullary thyroid carcinoma – Sometimes elevated.
• Acute brain injury – Stroke, trauma, or prolonged seizures can cause transient increases.

I remind my patients that false positives can occur with haemolysis (red blood cell breakdown) during blood draw, so repeat testing is often warranted before making any major decisions.

What About Low NSE Levels?

Low NSE is generally considered normal and not a cause for clinical concern. Extremely low values may occur in conditions associated with neuronal loss, but this is rarely used as a diagnostic criterion.

NSE During Pregnancy

Pregnancy does not significantly alter NSE levels. The reference interval remains similar to non-pregnant adults. However, because some neuroendocrine tumours are hormone-sensitive, NSE can still be used cautiously to monitor known cancers during pregnancy under specialist supervision.

Is High NSE Dangerous?

An isolated high NSE is not immediately dangerous, but it may indicate an underlying condition that requires prompt attention. If your NSE is elevated, your doctor will correlate it with imaging, other tumour markers (like CEA, ProGRP), and clinical findings. In the context of brain injury, very high NSE (>30 µg/L) has been linked to worse neurologic outcomes.

How Is the NSE Test Performed?

A standard blood sample is taken from a vein. No special preparation (fasting) is needed. The sample should be handled carefully to avoid haemolysis, which artificially raises NSE because red blood cells contain enolase.

Limitations of the NSE Test

NSE is not a screening test for the general population. Its main utility lies in monitoring known disease. False elevations can occur with haemolysis, severe infection, or hyperthermia. Also, some patients with SCLC have normal NSE, so a negative test does not rule out the disease.

When Should You Discuss NSE Results With Your Doctor?

Always review your results with a healthcare provider. If you have a known neuroendocrine tumour or have suffered a head injury, a single elevated NSE may not be actionable, but rising trends on serial testing often prompt further investigation. My patients typically ask: “What does my number mean compared to last time?” – trend analysis is far more informative than a single value.